These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 3656706

  • 1. [Comparative studies of plasma and urine levels between uremic peak 2a and guanidino compounds].
    Koide K, Toyama J, Inoue N, Koshikawa S, Akizawa T, Takahashi K, Hidaka S, Yamane Y, Nakao M, Ono S.
    Nihon Jinzo Gakkai Shi; 1987 Apr; 29(4):485-92. PubMed ID: 3656706
    [No Abstract] [Full Text] [Related]

  • 2. [Nitrogen metabolism and chronic renal insufficiency].
    Richet G, Meyerovitch A.
    Bull Mem Soc Med Hop Paris; 1968 Apr; 119(12):977-80. PubMed ID: 5719333
    [No Abstract] [Full Text] [Related]

  • 3. [On the behavior of phenols and creatinine in renal insufficiency, especilly in chronic dialysis patients].
    Jutzler GA, Kramer HJ, Keller HE, Kramer H, Doenecke F.
    Arch Klin Med; 1968 Apr; 214(3):214-43. PubMed ID: 5683859
    [No Abstract] [Full Text] [Related]

  • 4. The presence and toxicity of guanidinoproprionic acid in uremia.
    Shainkin R, Giatt Y, Berlyne GM.
    Kidney Int Suppl; 1975 Feb; (3):302-5. PubMed ID: 1057703
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Oxalate behavior in patients undergoing periodic hemodialytic treatments].
    Zucchelli P, Fusaroli M, Sasdelli M, Stallone C.
    Minerva Nefrol; 1970 Feb; 17(6):184-6. PubMed ID: 5516052
    [No Abstract] [Full Text] [Related]

  • 7. [Chronic renal failure and guanidino compounds].
    Kinoshita T.
    Yakugaku Zasshi; 1997 Nov; 117(10-11):673-80. PubMed ID: 9414581
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 10. Zinc metabolism in uremia.
    Mahajan SK, Prasad AS, Rabbani P, Briggs WA, McDonald FD.
    J Lab Clin Med; 1979 Nov; 94(5):693-8. PubMed ID: 501198
    [Abstract] [Full Text] [Related]

  • 11. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis.
    De Deyn PP, Marescau B, Swartz RD, Hogaerth R, Possemiers I, Lowenthal A.
    Nephron; 1990 Nov; 54(4):307-12. PubMed ID: 2325795
    [Abstract] [Full Text] [Related]

  • 12. Profound mishandling of protein glycation degradation products in uremia and dialysis.
    Agalou S, Ahmed N, Babaei-Jadidi R, Dawnay A, Thornalley PJ.
    J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
    [Abstract] [Full Text] [Related]

  • 13. Protein in the diets of dialyzed and non-dialyzed uremic patients. Study with nitrogen-labeled urea.
    Smith EB, Hill PA.
    J Am Diet Assoc; 1972 May; 60(5):389-93. PubMed ID: 5018368
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Blood and urine uric acid in chronic renal insufficiency].
    Burian AE, Dobrova AS.
    Klin Med (Mosk); 1979 Aug; 57(8):43-6. PubMed ID: 502412
    [No Abstract] [Full Text] [Related]

  • 16. Biochemistry of renal failure.
    Wills MR, Savory J.
    Ann Clin Lab Sci; 1981 Aug; 11(4):292-9. PubMed ID: 7023344
    [Abstract] [Full Text] [Related]

  • 17. Renal handling of middle molecules in uremic patients and in the isolated rat kidney.
    Lustenberger N, Schindhelm K, Nordmeyer C, Schurek HJ, Stolte H.
    Artif Organs; 1981 Aug; 4 Suppl():110-4. PubMed ID: 7295076
    [Abstract] [Full Text] [Related]

  • 18. Guanidino compounds and hemodialysis.
    Ochiai Y, Abe S, Yamada T, Tada K, Kosaka F.
    Adv Exp Med Biol; 1982 Aug; 153():459-64. PubMed ID: 7164919
    [No Abstract] [Full Text] [Related]

  • 19. [Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].
    Caravaca F, Arrobas M, Luna E, Naranjo M, Pizarro JL, Sánchez-Casado E.
    Nefrologia; 2002 Aug; 22(5):432-7. PubMed ID: 12497744
    [Abstract] [Full Text] [Related]

  • 20. [Methylguanidine (MG) movement of serum and urine in chronic renal failure (author's transl)].
    Ishizaki M, Aoyama K, Uno C, Kobayashi S, Asano H, Takahashi H, Momma H, Sekino H, Shishito S, Saito H.
    Nihon Jinzo Gakkai Shi; 1979 May; 21(3):175-84. PubMed ID: 470228
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.